TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 131 filers reported holding TRANSENTERIX INC in Q3 2019. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $27,000 | -55.0% | 42,952 | -3.4% | 0.00% | – |
| Q2 2019 | $60,000 | -45.0% | 44,477 | -2.5% | 0.00% | – |
| Q1 2019 | $109,000 | +6.9% | 45,607 | +1.1% | 0.00% | – |
| Q4 2018 | $102,000 | -62.5% | 45,104 | -3.8% | 0.00% | -100.0% |
| Q3 2018 | $272,000 | +58.1% | 46,869 | +19.1% | 0.00% | 0.0% |
| Q2 2018 | $172,000 | +117.7% | 39,354 | -15.6% | 0.00% | – |
| Q1 2018 | $79,000 | +119.4% | 46,628 | +151.3% | 0.00% | – |
| Q4 2017 | $36,000 | +5.9% | 18,554 | -21.8% | 0.00% | – |
| Q3 2017 | $34,000 | +183.3% | 23,736 | +43.8% | 0.00% | – |
| Q2 2017 | $12,000 | +9.1% | 16,504 | +83.3% | 0.00% | – |
| Q1 2017 | $11,000 | +120.0% | 9,004 | +124.9% | 0.00% | – |
| Q4 2016 | $5,000 | -66.7% | 4,004 | -55.5% | 0.00% | – |
| Q3 2016 | $15,000 | +36.4% | 9,004 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | -31.2% | 9,004 | +132.1% | 0.00% | – |
| Q1 2016 | $16,000 | – | 3,879 | +193850.0% | 0.00% | – |
| Q3 2015 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
| StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
| Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
| Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
| BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |